12 results
6-K
EX-99.4
GRCL
Gracell Biotechnologies Inc
26 Dec 23
Voting and Support Agreement
8:12am
experts will be instrumental in continuing to advance the companies’ combined vision and mission. William will also be a member of the Oncology Cell
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
7 Aug 23
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
8:07am
FasTCAR GC012F candidate for hematological cancers and autoimmune diseases, and their support for our mission to develop revolutionizing cell
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
16 Nov 22
Current report (foreign)
6:03am
Gracell with a mission to develop highly efficacious and affordable breakthrough cell therapies that address vast unmet needs and we look forward
424B4
7wsjgzuum56c3lukhhsb
8 Jan 21
Prospectus supplement with pricing info
1:42pm
F-1/A
p7qnglhl
7 Jan 21
Registration statement (foreign) (amended)
7:03am
F-1/A
gviin9723v6o6usa0z
6 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
txt2v
4 Jan 21
Registration statement (foreign) (amended)
9:30am
F-1
6bsln 2gv1
18 Dec 20
Registration statement (foreign)
4:18pm
DRS/A
7e2g5e7ai1qfszvu
24 Nov 20
Draft registration statement (amended)
12:00am
DRS
2zy65d4bueymrd
19 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next